CARM1 and non-small cell lung carcinoma: The expression of circHMGB2 was significantly upregulated in NSCLC tissues, and circHMGB2 relieved the inhibition of downstream CARM1 by sponging miR-181a-5p, thus inactivating the type 1 interferon response in NSCLC tissues.